IV-23
IV-23 (Compound 20) is a potent Noxa mediated apoptosis inducer, and it is a promising anticancer agent with potential. IV-23 inhibits cell growths in vitro and in vivo, reduces colony formation, arrests cell cycle at M phase, and induces esophageal squamous cell carcinoma (ESCC).
For research use only. We do not sell to patients.
- CAS No.: 2326007-49-0
- Formula: C18H18BrNO4
- Molecular Weight:392.24
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
6.82 μM
Compound: 9d
|
Antiproliferative activity against human A549 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human A549 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| A549 | IC50 |
6.82 μM
Compound: 9d
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
| ECa-109 cell line | IC50 |
2.24 μM
Compound: 9d
|
Antiproliferative activity against human Eca-109 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human Eca-109 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| ECa-109 cell line | IC50 |
2.24 μM
Compound: 9d
|
Antiproliferative activity against human Eca-109 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human Eca-109 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
| KYSE-30 | IC50 |
1.61 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-30 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-30 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| KYSE-30 | IC50 |
1.61 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-30 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-30 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
| KYSE-450 | IC50 |
1.49 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-450 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-450 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| KYSE-450 | IC50 |
1.49 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-450 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-450 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
| KYSE-510 | IC50 |
2.08 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-510 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-510 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| KYSE-510 | IC50 |
2.08 μM
Compound: 9d
|
Antiproliferative activity against human KYSE-510 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human KYSE-510 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
| MGC-803 | IC50 |
1.84 μM
Compound: 9d
|
Antiproliferative activity against human MGC-803 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human MGC-803 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 33965530] |
| MGC-803 | IC50 |
1.84 μM
Compound: 9d
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 48 hrs by CCK8 assay
|
[PMID: 34022412] |
IV-23 (Compound 20) shows a strong inhibition against the ESCCs in a concentration depend manner, the IC50 values against the Kyse30 and Kyse450 cell lines were all less than 2 μM, presented in a dose-dependent manner. IV-23 triggeres caspases related apoptosis in ESCC cells[1].
IV-23 induces G2/M phase arrest[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2326007-49-0
-
Molecular Weight 392.24
-
Formula C18H18BrNO4
-
SMILES
O=C(N1CCC2=C1C=CC(Br)=C2)C3=CC(OC)=C(OC)C(OC)=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)